FDA Inspection 1151754 — Singha North America

Singha North America — FEI 3009161974

The FDA completed an inspection of Singha North America on September 30, 2021 in Redwood City, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 30, 2021
Fiscal Year
2021
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Redwood City, CA (United States)

Additional Details

FSVP

Citations

IDCFRDescription
1825421 CFR 1.502(a)Develop FSVP
1827221 CFR 1.504(d)Document review entity's hazard analysis
1828121 CFR 1.505(a)(2)Evaluation - performance, risk
1829021 CFR 1.506(a)(1)Approved supplier procedures - importer established